FreeStyle Libre System
The #1 sensor-based glucose monitoring systems used worldwide1
References & Disclaimers
Images are for illustrative purposes only. Not real patient, data, or healthcare professional.
^ FreeStyle Libre systems are part of the same family of products.
† Finger pricks are required if glucose readings do not match symptoms or expectations.
1. Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre systems compared to the number of users for other leading personal use sensor-based glucose monitoring systems.
2. Mark Evans, Zöe Welsh, Sara Ells, Alexander Seibold. “The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-Analysis of Clinical Trials and Real-World Observational Studies.” Diabetes Therapy 11, no. 1 (2020):83–95. https://doi.org/10.1007/s13300-019-00720-0.
3. Marion Fokkert, Peter van Dijk, Mireille Edens, Eglantine Barents, Jeanine Mollema, Robert Slingerland, Reinhold Gans, Henk Bilo. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research & Care 7, e000809 (2019). https://doi.org/10.1136/bmjdrc-2019-000809.
4. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes 2019 Jun; 68(Supplement 1).
5. Unger, J., Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
6. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.